Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06208514 · ClinicalTrials.gov registry record · NA

Brief Pain Exposure Therapy (BPET) For Nociplastic Pain

A NA study of Fibromyalgia and Lupus Erythematosus, Systemic, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT06208514 is a NA study of Fibromyalgia and Lupus Erythematosus, Systemic that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 125 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06208514, a NA study of Fibromyalgia and Lupus Erythematosus, Systemic, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).

Interventions

  • BEHAVIORAL Brief pain exposure therapy (BPET)

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2024-03-04
Est. Completion 2026-07
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06208514

The ClinicalTrials.gov registry entry for NCT06208514 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (30% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Brief pain exposure therapy (BPET) is the first listed.

NCT06208514 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06208514 about?

NCT06208514 is a clinical study titled "Brief Pain Exposure Therapy (BPET) For Nociplastic Pain". This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pel...

What is the current status of trial NCT06208514?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2024-03-04. Estimated completion is 2026-07.

What conditions does trial NCT06208514 study?

This clinical trial studies the following conditions: Fibromyalgia, Lupus Erythematosus, Systemic, Chronic Low Back Pain (CLBP), Chronic Pelvic Pain.

What interventions are being tested in trial NCT06208514?

The interventions under investigation include: Brief pain exposure therapy (BPET) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06208514?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06208514 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.